A Novel Role For Plexin A in Photoreceptor Axon Targeting

Plexin A 在光感受器轴突靶向中的新作用

基本信息

项目摘要

Project Summary Formation of complex neural circuits must be precisely controlled during the development of the nervous system. Axons navigate to their targets by detecting both long-range and short-range signals presented by cells in the environment that can act as attractants or repellants. Defects in axon guidance and targeting can result in a number of neurodevelopmental disorders, such as epilepsy, schizophrenia, Autism Spectrum Disorders, and intelligence disabilities. The Drosophila visual system is an excellent model system for studying the basic mechanisms of axon guidance and neural circuit formation. The terminals of R7 and R8 photoreceptors, responsible for different aspects of color vision, are segregated into distinct target layers of the medulla, a central region of visual processing in the brain. Photoreceptors also must project in a retinotopic manner to maintain a precise representation of the visual field within the brain. In a screen for molecules that control color photoreceptor axon targeting, knocking down plexin A (plexA) in the brain using RNAi caused R7 photoreceptors to prematurely terminate in the R8 target layer of the medulla and fail to expand their axon terminals. A protein null mutation in plexA (plexAMb09499) caused by a Minos element insertion in a coding exon has the same effect on R7 axons. plexA is required in neurons, but not in photoreceptors, for R7 to reach the correct target layer. PlexA protein is expressed close to this target layer, suggesting that it may act as an attractive signal for R7 axons, in contrast to its known role in repelling L3 lamina neuron axons from this layer. Mosaic analysis will be used to confirm that this is the site of PlexA action. Overexpression of PlexA or a truncated form lacking the cytoplasmic domain in photoreceptors results in hyperfasciculation and premature termination of their axons. This misexpression phenotype will be used to characterize the mechanism of PlexA action and test the hypothesis that PlexA acts as an attractive or adhesive signal for photoreceptors. The known receptor and ligand for PlexA, Semaphorin- 1a, is not required for normal targeting of R7 photoreceptors. We will investigate whether PlexA instead interacts with an uncharacterized CUB domain protein, CG6024; knocking down CG6024 in photoreceptors using RNAi also disrupts R7 targeting. Homologs of PlexA have been studied in the organization of the vertebrate retina, and Plexin family members also participate in regulation of the immune response, heart and vessel formation, and even the progression of cancer. Preliminary results suggest that PlexA controls R7 targeting through a novel signaling mechanism, distinct from those previously described. Therefore, this work may provide new insight into the mechanisms that control a variety of developmental and disease processes in higher organisms.
项目摘要 在开发过程中必须精确控制复杂的神经回路的形成 神经系统。轴突通过检测远程和短距离信号来导航到目标 由细胞在环境中呈现,可以充当吸引者或驱虫剂。轴突中的缺陷 指导和靶向可能导致许多神经发育障碍,例如癫痫, 精神分裂症,自闭症谱系障碍和智力障碍。果蝇视觉系统 是研究轴突指导和神经回路的基本机制的出色模型系统 形成。 R7和R8光感受器的终端,负责色觉的不同方面, 被隔离为髓质的不同目标层,髓质是视觉处理的中心区域 脑。感光体还必须以视网膜量进行投射,以保持 大脑内的视野。在控制颜色光感受器轴突的分子的屏幕中 靶向,使用RNAi在大脑中击倒plexin A(Plexa)导致R7感光体 过早终止在髓质的R8目标层中,无法扩展其轴突终端。一个 由Minos元素在编码外显子中插入的PLEXA中的蛋白质零突变(Plexamb09499) 对R7轴突的影响相同。在神经元中,需要PlexA,而在感光器中不需要Plexa才能达到R7 正确的目标层。 Plexa蛋白靠近该目标层,表明它可能作用 作为R7轴突的有吸引力的信号,与其在排斥L3层神经元轴突中的已知作用相反 从这个层。马赛克分析将用于确认这是Plexa作用的位置。 在光感受器中缺少细胞质结构域的PLEXA或截短形式的过表达结果 在高血管和轴突的过早终止中。这种Misexpression表型将是 用于表征Plexa作用机制并检验Plexa充当的假设 感光体的吸引力或粘合信号。 Plexa,Semaphorin-的已知受体和配体 1A,不需要正常的R7光感受器靶向。我们将调查是否相反 与未表征的Cub结构蛋白CG6024相互作用;击倒CG6024 使用RNAi感受器也破坏R7靶向。 Plexa的同源物已在 脊椎动物视网膜的组织和plexin家族成员也参与监管 免疫反应,心脏和血管形成,甚至是癌症的进展。初步结果 建议PLEXA通过一种新型信号传导机制来控制R7的靶向,与之不同 先前描述的。因此,这项工作可能会为控制A的机制提供新的见解 较高生物体的多种发育和疾病过程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica P Douthit其他文献

Jessica P Douthit的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jessica P Douthit', 18)}}的其他基金

A Novel Role For Plexin A in Photoreceptor Axon Targeting
Plexin A 在光感受器轴突靶向中的新作用
  • 批准号:
    9360542
  • 财政年份:
    2016
  • 资助金额:
    $ 3.43万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
  • 批准号:
    10752274
  • 财政年份:
    2024
  • 资助金额:
    $ 3.43万
  • 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
  • 批准号:
    10750357
  • 财政年份:
    2023
  • 资助金额:
    $ 3.43万
  • 项目类别:
Pre-mRNA Processing and Function of Alternatively Spliced Isoforms of TFPI
TFPI 选择性剪接亚型的前 mRNA 加工和功能
  • 批准号:
    10664506
  • 财政年份:
    2023
  • 资助金额:
    $ 3.43万
  • 项目类别:
Regulation of Flt 1 Splicing by Fibronectin and Integrin Signaling During Aging
衰老过程中纤连蛋白和整合素信号传导对 Flt 1 剪接的调节
  • 批准号:
    10777172
  • 财政年份:
    2023
  • 资助金额:
    $ 3.43万
  • 项目类别:
IND Enabling Non-Clinical Development of E1v1.11, a Morpholino Anti-Sense Oligonucleotide for the treatment of Spinal Muscular Atrophy.
IND 促进 E1v1.11 的非临床开发,E1v1.11 是一种用于治疗脊髓性肌萎缩症的吗啉代反义寡核苷酸。
  • 批准号:
    10569744
  • 财政年份:
    2023
  • 资助金额:
    $ 3.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了